CPAI - ETF AI Analysis
Top Page
Counterpoint Quantitative Equity ETF (CPAI)
Rating:60Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains over the past year-to-date and recent months, indicating positive momentum.
Top Holdings with Solid Gains
Many of the largest positions, including companies in energy, technology, and specialty materials, have delivered strong year-to-date performance that supports the fund’s returns.
Broad Sector Diversification
Holdings spread across health care, technology, industrials, materials, consumer sectors, financials, energy, and communications help reduce the impact of weakness in any single industry.
Negative Factors
High Expense Ratio
The fund’s relatively high fee means more of the investment return goes to costs instead of staying in investors’ pockets.
Heavy U.S. Concentration
With the vast majority of assets in U.S. stocks and only a small slice abroad, investors get limited geographic diversification.
Smaller Asset Base
The fund’s modest size may lead to lower trading volume and potentially wider bid-ask spreads compared with larger, more established ETFs.
CPAI vs. SPDR S&P 500 ETF (SPY)
AUM239.38M
RegionNorth America
Expense Ratio0.75%
Beta1.04
IssuerCounterpoint
Inception DateNov 28, 2023
Dividend Yield0.79%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume48,870
30 Day Avg. Volume49,310
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
57.91Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CPAI Summary
The Counterpoint Quantitative Equity ETF (CPAI) is an actively managed fund that aims to cover almost the entire U.S. stock market, using a data-driven approach instead of tracking a set index. It mixes different sizes and styles of companies, from growth to value, across many sectors like health care, technology, and industrials. Well-known holdings include Micron and Herbalife. Someone might invest in CPAI to get broad diversification and long-term growth potential in a single fund. A key risk is that it still moves with the overall stock market, so its value can go up and down significantly.
How much will it cost me?The Counterpoint Quantitative Equity ETF (CPAI) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is actively managed, using a quantitative approach to select stocks rather than simply tracking an index.
What would affect this ETF?The Counterpoint Quantitative Equity ETF (CPAI), with its focus on the U.S. market and diverse sector exposure, could benefit from strong growth in technology and healthcare sectors, driven by innovation and increased demand. However, it may face challenges from rising interest rates or economic slowdowns, which could negatively impact consumer spending and cyclical industries. Regulatory changes or geopolitical tensions affecting North America could also influence the ETF's performance.
CPAI Top 10 Holdings
CPAI’s story is driven by a handful of punchy U.S. names rather than sleepy blue chips. Micron is a key engine, with its AI-focused chip business keeping returns on an upward track, while Tower Semiconductor and Clear Secure add to the fund’s momentum with steadily improving trends. On the flip side, Brookdale Senior Living and Qnity Electronics look more like dead weight, with softer recent moves that dull the overall shine. Energy plays like PBF Energy and Delek US are rising again, giving the portfolio a cyclical tilt on top of its tech-heavy flavor.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Credo Technology Group Holding Ltd | 3.19% | $7.61M | $31.05B | 307.15% | 77 Outperform | |
| Astera Labs, Inc. | 2.86% | $6.84M | $29.29B | 190.21% | 68 Neutral | |
| Lightpath Technologies | 2.66% | $6.35M | $809.07M | 577.29% | 53 Neutral | |
| Micron | 2.56% | $6.11M | $514.51B | 558.06% | 79 Outperform | |
| Teradyne | 2.30% | $5.49M | $57.14B | 412.87% | 71 Outperform | |
| Viavi Solutions | 2.28% | $5.45M | $9.08B | 296.56% | 71 Outperform | |
| EZCORP | 2.20% | $5.26M | $1.81B | 85.57% | 75 Outperform | |
| RealReal | 2.19% | $5.23M | $1.25B | 107.66% | 54 Neutral | |
| Alphabet Class A | 2.14% | $5.11M | $4.06T | 119.86% | 85 Outperform | |
| Centene | 2.12% | $5.06M | $18.49B | -39.34% | 58 Neutral |
CPAI Technical Analysis
Positive
―
Price Trends
42.98
Positive
42.17
Positive
39.81
Positive
Market Momentum
0.43
Negative
64.87
Neutral
97.89
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CPAI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 42.56, equal to the 50-day MA of 42.98, and equal to the 200-day MA of 39.81, indicating a bullish trend. The MACD of 0.43 indicates Negative momentum. The RSI at 64.87 is Neutral, neither overbought nor oversold. The STOCH value of 97.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CPAI.
CPAI Peer Comparison
Comparison Results
Performance Comparison
CPAI
Counterpoint Quantitative Equity ETF
45.26
14.07
45.11%
SYLD
Cambria Shareholder Yield ETF
―
―
―
ULTY
YieldMax Ultra Option Income Strategy ETF
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
XCHG
AB US Equity ETF
―
―
―
EBI
Longview Advantage ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents